Yaara Leibovici-Weisman

Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged ≥60 Years.

S. Stemmer, N. Eliakim‐Raz, A. Stemmer, 2021, JAMA.

Three-month follow-up of durability of response to the third dose of the SARS-CoV-2 BNT162b2 vaccine in adults aged 60 years and older: a prospective cohort study

N. Moskovits, A. Levy-Barda, N. Erez, 2022, BMJ Open.

Antibody Titers After a Third and Fourth SARS-CoV-2 BNT162b2 Vaccine Dose in Older Adults

S. Stemmer, N. Eliakim‐Raz, A. Stemmer, 2022, JAMA Network Open.